{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:59:41Z","timestamp":1786996781788,"version":"build-2736575974"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.semperi.2025.152040","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:23:25Z","timestamp":1741843405000},"page":"152040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Melanoma in pregnancy"],"prefix":"10.1016","volume":"49","author":[{"given":"Christina S.","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth F.","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy K.","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10400","key":"10.1016\/j.semperi.2025.152040_bib0001","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.semperi.2025.152040_bib0002","unstructured":"Heistein J.B.A., U.; Mukkamalla S. K. R. Malignant melanoma. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470409\/."},{"key":"10.1016\/j.semperi.2025.152040_bib0003","unstructured":"SEER*explorer: an interactive website for SEER cancer statistics [Internet]. National cancer institute. 2024 Apr 17. Accessed 2024 Aug 26. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/."},{"issue":"Suppl 1","key":"10.1016\/j.semperi.2025.152040_bib0004","article-title":"Epidemiology and risk factors of melanoma: a review","volume":"11","author":"Conforti","year":"2021","journal-title":"Dermatol Pract Concept"},{"issue":"16","key":"10.1016\/j.semperi.2025.152040_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10163760","article-title":"Familial melanoma and susceptibility genes: a review of the most common clinical and dermoscopic phenotypic aspect, associated malignancies and practical tips for management","volume":"10","author":"Zocchi","year":"2021","journal-title":"J Clin Med"},{"issue":"16","key":"10.1016\/j.semperi.2025.152040_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164026","article-title":"BRAF mutations in melanoma: biological aspects, therapeutic implications, and circulating biomarkers","volume":"15","author":"Castellani","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.semperi.2025.152040_bib0007","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152040_bib0008","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10552-008-9110-4","article-title":"Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues","volume":"19","author":"Lens","year":"2008","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0009","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/CMR.0000000000000953","article-title":"Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020","volume":"34","author":"Davidson","year":"2024","journal-title":"Melanoma Res"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1753495X17695001","article-title":"Melanoma in pregnancy","volume":"10","author":"Still","year":"2017","journal-title":"Obstet Med"},{"issue":"4","key":"10.1016\/j.semperi.2025.152040_bib0011","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/aogs.14677","article-title":"Risk factors for the increasing incidence of pregnancy-associated cancer in Sweden - a population-based study","volume":"103","author":"Lundberg","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"11","key":"10.1016\/j.semperi.2025.152040_bib0012","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0025-6196(11)60669-1","article-title":"Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents","volume":"84","author":"Holtan","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.semperi.2025.152040_bib0013","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1078-0432.CCR-08-1980","article-title":"Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma","volume":"15","author":"Nevala","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.semperi.2025.152040_bib0014","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.ajpath.2010.12.044","article-title":"Pregnancy promotes melanoma metastasis through enhanced lymphangiogenesis","volume":"178","author":"Khosrotehrani","year":"2011","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152040_bib0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3892\/ol.2022.13289","article-title":"Tyrosinase suppresses vasculogenic mimicry in human melanoma cells","volume":"23","author":"Kamo","year":"2022","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1016\/j.semperi.2025.152040_bib0016","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jaad.2016.01.060","article-title":"Nevi and pregnancy","volume":"75","author":"Bieber","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152040_bib0017","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/GRF.0000000000000077","article-title":"Physiological skin changes during pregnancy","volume":"58","author":"Tyler","year":"2015","journal-title":"Clin Obstet Gynecol"},{"issue":"Suppl 23","key":"10.1016\/j.semperi.2025.152040_bib0018","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2133.1982.tb01035.x","article-title":"Steroid hormone receptor analysis in human melanoma and non-malignant human skin","volume":"107","author":"Grill","year":"1982","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152040_bib0019","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/1523-1747.ep12544454","article-title":"Steroid hormone receptors and melanoma","volume":"74","author":"Neifeld","year":"1980","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/1097-0142(195103)4:2<324::AID-CNCR2820040218>3.0.CO;2-G","article-title":"The prognosis for malignant melanoma in the pregnant woman","volume":"4","author":"Pack","year":"1951","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0021","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00007611-195403000-00002","article-title":"The effect of pregnancy on the clinical course of malignant melanoma","volume":"47","author":"Byrd","year":"1954","journal-title":"South Med J"},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0022","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ajo.12279","article-title":"Incidence and outcomes of pregnancy-associated melanoma in New South Wales 1994-2008","volume":"55","author":"Bannister-Tyrrell","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"18","key":"10.1016\/j.semperi.2025.152040_bib0023","doi-asserted-by":"crossref","first-page":"15953","DOI":"10.18632\/oncotarget.3643","article-title":"Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion","volume":"6","author":"Prithviraj","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semperi.2025.152040_bib0024","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41598-017-19073-4","article-title":"Targeting insulin-like growth factor-I and extracellular matrix interactions in melanoma progression","volume":"8","author":"Murekatete","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.semperi.2025.152040_bib0025","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1523-1747.2000.00199.x","article-title":"Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor","volume":"115","author":"Lacal","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152040_bib0026","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaad.2016.01.061","article-title":"Pregnancy and melanoma","volume":"75","author":"Driscoll","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152040_bib0027","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jaad.2014.09.018","article-title":"Mortality in women with pregnancy-associated malignant melanoma","volume":"71","author":"Johansson","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"21","key":"10.1016\/j.semperi.2025.152040_bib0028","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1200\/JCO.2004.02.096","article-title":"Effect of pregnancy on survival in women with cutaneous malignant melanoma","volume":"22","author":"Lens","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152040_bib0029","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.2008.17.4110","article-title":"Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study","volume":"27","author":"Stensheim","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152040_bib0030","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cncr.20925","article-title":"Malignant melanoma in pregnancy. A population-based evaluation","volume":"103","author":"O'Meara","year":"2005","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.semperi.2025.152040_bib0031","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2009.22.2588","article-title":"Cutaneous melanoma during pregnancy: is the controversy over?","volume":"27","author":"Lens","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152040_bib0032","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/1097-0142(19850315)55:6<1340::AID-CNCR2820550630>3.0.CO;2-T","article-title":"Malignant melanoma and pregnancy","volume":"55","author":"Reintgen","year":"1985","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.semperi.2025.152040_bib0033","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00000658-199005000-00005","article-title":"Malignant melanoma arising during pregnancy. A study of 100 patients","volume":"211","author":"Slingluff","year":"1990","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.semperi.2025.152040_bib0034","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1471-0528.1989.tb06306.x","article-title":"Melanoma and pregnancy: a long-term follow-up","volume":"96","author":"McManamny","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"issue":"10","key":"10.1016\/j.semperi.2025.152040_bib0035","doi-asserted-by":"crossref","DOI":"10.1001\/archsurg.1989.01410100133023","article-title":"Prognostic significance of pregnancy in stage I melanoma","volume":"124","author":"Wong","year":"1989","journal-title":"Arch Surg"},{"issue":"12","key":"10.1016\/j.semperi.2025.152040_bib0036","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/cncr.29325","article-title":"Cancer during pregnancy and the postpartum period: a population-based study","volume":"121","author":"Andersson","year":"2015","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.semperi.2025.152040_bib0037","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.ejca.2013.06.047","article-title":"Recent childbirth is an adverse prognostic factor in breast cancer and melanoma, but not in Hodgkin lymphoma","volume":"49","author":"Moller","year":"2013","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.semperi.2025.152040_bib0038","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/CMR.0000000000000334","article-title":"Does pregnancy influence melanoma prognosis? A meta-analysis","volume":"27","author":"Kyrgidis","year":"2017","journal-title":"Melanoma Res"},{"issue":"100005","key":"10.1016\/j.semperi.2025.152040_bib0039","article-title":"Risk of materno-fetal transmission of melanoma cells in pregnant women with high grade melanoma \u2013 A retrospective multicenter study and literature review","volume":"1","author":"Wiedemann","year":"2023","journal-title":"EJC Skin Cancer"},{"issue":"1","key":"10.1016\/j.semperi.2025.152040_bib0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jso.23035","article-title":"A proposal for the timing of management of patients with melanoma presenting during pregnancy","volume":"106","author":"Broer","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.semperi.2025.152040_bib0041","article-title":"Familial Atypical Multiple Mole Melanoma Syndrome","author":"BM","year":"2009","journal-title":"Cancer Syndrom [Internet] Bethesda (MD)"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0042","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0190-9622(91)70227-S","article-title":"Pregnancy and sex steroid hormone effects on nevi of patients with the dysplastic nevus syndrome","volume":"25","author":"Ellis","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0043","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijwd.2017.11.006","article-title":"Pregnancy and melanoma: recommendations for clinical scenarios","volume":"4","author":"Berk-Krauss","year":"2018","journal-title":"Int J Womens Dermatol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0044","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2340\/00015555-0227","article-title":"Spectrophotometric analysis of melanocytic naevi during pregnancy","volume":"87","author":"Wyon","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152040_bib0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archderm.134.1.103-a","article-title":"The 'ugly duckling' sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening","volume":"134","author":"Grob","year":"1998","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152040_bib0046","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1684\/ejd.2021.4171","article-title":"Clinical ABCDE rule for early melanoma detection","volume":"31","author":"Duarte","year":"2021","journal-title":"Eur J Dermatol"},{"issue":"610","key":"10.1016\/j.semperi.2025.152040_bib0047","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.3399\/bjgp13X667213","article-title":"Using the 7-point checklist as a diagnostic aid for pigmented skin lesions in general practice: a diagnostic validation study","volume":"63","author":"Walter","year":"2013","journal-title":"Br J Gen Pract"},{"issue":"1","key":"10.1016\/j.semperi.2025.152040_bib0048","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaad.2018.08.055","article-title":"Guidelines of care for the management of primary cutaneous melanoma","volume":"80","author":"Swetter","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152040_bib0049","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.clindermatol.2008.09.009","article-title":"Nevi and melanoma in the pregnant woman","volume":"27","author":"Driscoll","year":"2009","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/OGX.0000000000001109","article-title":"Melanoma during pregnancy as a complicated medical problem","volume":"78","author":"Koscielecka","year":"2023","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0051","first-page":"248","article-title":"Dermatologic surgery and the pregnant patient","volume":"28","author":"Richards","year":"2002","journal-title":"Dermatol Surg"},{"issue":"2 Pt 1","key":"10.1016\/j.semperi.2025.152040_bib0052","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0190-9622(90)70211-Y","article-title":"Cutaneous surgery and the pregnant patient","volume":"23","author":"Gormley","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.semperi.2025.152040_bib0053","article-title":"Staging and follow-up","volume":"11","author":"Papageorgiou","year":"2021","journal-title":"Dermatol Pract Concept"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0054","first-page":"229","article-title":"The prognostic significance of the clinical and histological parameters in primary cutaneous melanoma patients","volume":"95","author":"Antohe","year":"2022","journal-title":"Med Pharm Rep"},{"issue":"4","key":"10.1016\/j.semperi.2025.152040_bib0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","article-title":"Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: american society of clinical oncology and society of surgical oncology clinical practice guideline update","volume":"36","author":"Wong","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semperi.2025.152040_bib0056","unstructured":"Pathak S.Z.P.M. Clinical guidelines for the staging, diagnosis, and management of cutaneous malignant melanoma. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572149\/."},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0057","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.reprotox.2009.05.001","article-title":"Fetal outcome after technetium scintigraphy in early pregnancy","volume":"28","author":"Schaefer","year":"2009","journal-title":"Reprod Toxicol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152040_bib0058","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1075-122X.2004.21503.x","article-title":"The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid","volume":"10","author":"Keleher","year":"2004","journal-title":"Breast J"},{"issue":"4","key":"10.1016\/j.semperi.2025.152040_bib0059","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/ajd.12568","article-title":"Melanoma and pregnancy","volume":"58","author":"Morton","year":"2017","journal-title":"Australas J Dermatol"},{"issue":"11","key":"10.1016\/j.semperi.2025.152040_bib0060","article-title":"Sentinel lymph node biopsy in cutaneous melanoma, a clinical point of view","volume":"58","author":"Branisteanu","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0061","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1245\/s10434-012-2633-7","article-title":"Sentinel lymph node biopsy for melanoma in pregnant women","volume":"20","author":"Andtbacka","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.semperi.2025.152040_bib0062","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejca.2022.02.016","article-title":"Melanoma in pregnancy: diagnosis and management in early-stage and advanced disease","volume":"166","author":"Carter","year":"2022","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.semperi.2025.152040_bib0063","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/bjs.11112","article-title":"Prospective cohort study of ultrasound surveillance of regional lymph nodes in patients with intermediate-risk cutaneous melanoma","volume":"106","author":"Hayes","year":"2019","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.semperi.2025.152040_bib0064","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/SLA.0000000000003405","article-title":"Preoperative ultrasound assessment of regional lymph nodes in melanoma patients does not provide reliable nodal staging: results from a large multicenter trial","volume":"273","author":"Thompson","year":"2021","journal-title":"Ann Surg"},{"issue":"860","key":"10.1016\/j.semperi.2025.152040_bib0065","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1259\/bjr.72.860.10624343","article-title":"Fetal doses from radiological examinations","volume":"72","author":"Osei","year":"1999","journal-title":"Br J Radiol"},{"issue":"12","key":"10.1016\/j.semperi.2025.152040_bib0066","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16122173","article-title":"Melanoma in pregnancy-diagnosis, treatment, and consequences for fetal development and the maintenance of pregnancy","volume":"16","author":"Pelczar","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.semperi.2025.152040_bib0067","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1610-0387.2006.06055.x","article-title":"Diagnostic and therapeutic procedures for management of melanoma during pregnancy: risks for the fetus?","volume":"4","author":"Egberts","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0068","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ejca.2006.11.014","article-title":"Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma","volume":"43","author":"Pfannenberg","year":"2007","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.semperi.2025.152040_bib0069","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cps.2021.06.004","article-title":"Melanoma in pregnancy and pediatrics","volume":"48","author":"Romanelli","year":"2021","journal-title":"Clin Plast Surg"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jso.24111","article-title":"The importance of surgical margins in melanoma","volume":"113","author":"Ethun","year":"2016","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0071","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/XCS.0000000000000481","article-title":"Setting the standard for cutaneous melanoma wide local excision: an overview of the American college of surgeons commission on cancer standard 5.5","volume":"236","author":"Lillemoe","year":"2023","journal-title":"J Am Coll Surg"},{"issue":"4","key":"10.1016\/j.semperi.2025.152040_bib0072","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaad.2020.10.099","article-title":"Preventing complications in dermatologic surgery: presurgical concerns","volume":"84","author":"Strickler","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"30","key":"10.1016\/j.semperi.2025.152040_bib0073","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1200\/JCO.23.01136","article-title":"Systemic therapy for melanoma: ASCO guideline update","volume":"41","author":"Seth","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.semperi.2025.152040_bib0074","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/XCS.0000000000000088","article-title":"Treat now or Treat later: comparative effectiveness of adjuvant therapy in resected stage IIIA melanoma","volume":"234","author":"Ma","year":"2022","journal-title":"J Am Coll Surg"},{"issue":"5","key":"10.1016\/j.semperi.2025.152040_bib0075","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1007\/s00261-022-03796-8","article-title":"Melanoma in pregnancy","volume":"48","author":"Czeyda-Pommersheim","year":"2023","journal-title":"Abdom Radiol (NY)"},{"issue":"12","key":"10.1016\/j.semperi.2025.152040_bib0076","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1016\/S1470-2045(21)00525-8","article-title":"Immunotherapy for cancer treatment during pregnancy","volume":"22","author":"Borgers","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152040_bib0077","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.semperi.2025.152040_bib0078","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.semperi.2025.152040_bib0079","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined Nivolumab and Ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.semperi.2025.152040_bib0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0081","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.20050019","article-title":"A critical role for the programmed death ligand 1 in fetomaternal tolerance","volume":"202","author":"Guleria","year":"2005","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.semperi.2025.152040_bib0082","doi-asserted-by":"crossref","first-page":"e12850","DOI":"10.1111\/aji.12850","article-title":"Placenta immune infiltrates and perinatal outcomes","volume":"79","author":"Ozen","year":"2018","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0083","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/aji.12365","article-title":"Recent insight into the role of the PD-1\/PD-L1 pathway in feto-maternal tolerance and pregnancy","volume":"74","author":"Zhang","year":"2015","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0084","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/bdrb.21176","article-title":"An evaluation of the impact of PD-1 pathway blockade on reproductive safety of therapeutic PD-1 inhibitors","volume":"107","author":"Poulet","year":"2016","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0085","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1476-5381.2011.01811.x","article-title":"Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets","volume":"166","author":"Bugelski","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152040_bib0086","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41419-018-1251-0","article-title":"Blockade of CTLA-4 and Tim-3 pathways induces fetal loss with altered cytokine profiles by decidual CD4(+)T cells","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0087","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/CMR.0000000000000586","article-title":"Pregnancy with successful foetal and maternal outcome in a melanoma patient treated with nivolumab in the first trimester: case report and review of the literature","volume":"29","author":"Xu","year":"2019","journal-title":"Melanoma Res"},{"key":"10.1016\/j.semperi.2025.152040_bib0088","first-page":"1","article-title":"Case report of a pregnancy during ipilimumab therapy","volume":"4","author":"Mehta","year":"2018","journal-title":"J Glob Oncol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0089","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.seminoncol.2018.03.003","article-title":"Viable pregnancy in a patient with metastatic melanoma treated with double checkpoint immunotherapy","volume":"45","author":"Burotto","year":"2018","journal-title":"Semin Oncol"},{"key":"10.1016\/j.semperi.2025.152040_bib0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejca.2018.09.008","article-title":"Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy","volume":"104","author":"Menzer","year":"2018","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.semperi.2025.152040_bib0091","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/CMR.0000000000000657","article-title":"Conception and viable twin pregnancy in a patient with metastatic melanoma while treated with CTLA-4 and PD-1 checkpoint inhibition","volume":"30","author":"Bucheit","year":"2020","journal-title":"Melanoma Res"},{"issue":"5","key":"10.1016\/j.semperi.2025.152040_bib0092","first-page":"762","article-title":"Pregnancy in a patient with metastatic uveal melanoma treated with nivolumab","volume":"19","author":"Haiduk","year":"2021","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"10.1016\/j.semperi.2025.152040_bib0093","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3892\/mco.2021.2404","article-title":"Malignant melanoma treated with pembrolizumab during pregnancy: a case report and review of the literature","volume":"15","author":"Anami","year":"2021","journal-title":"Mol Clin Oncol"},{"issue":"5","key":"10.1016\/j.semperi.2025.152040_bib0094","first-page":"619","article-title":"Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients","volume":"70","author":"Creagan","year":"1986","journal-title":"Cancer Treat Rep"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.reprotox.2011.11.003","article-title":"A systematic review of the fetal safety of interferon alpha","volume":"33","author":"Yazdani Brojeni","year":"2012","journal-title":"Reprod Toxicol"},{"issue":"10","key":"10.1016\/j.semperi.2025.152040_bib0096","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12666","article-title":"Association of treatments for myeloproliferative neoplasms during pregnancy with birth rates and maternal outcomes: a systematic review and meta-analysis","volume":"2","author":"Maze","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.semperi.2025.152040_bib0097","unstructured":"Sosman J.A. Interleukin 2 and experimental immunotherapy approaches for advanced melanoma. In: Atkins MB, ed. Post TW (Ed); 2023."},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0098","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/eji.201948382","article-title":"Immune checkpoint molecules in pregnancy: focus on regulatory T cells","volume":"50","author":"Zhang","year":"2020","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152040_bib0099","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1758834015616934","article-title":"Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy","volume":"8","author":"Eroglu","year":"2016","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/CCO.0000000000000614","article-title":"Targeting BRAF and MEK inhibitors in melanoma in the metastatic, neoadjuvant and adjuvant setting","volume":"32","author":"Tetu","year":"2020","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"10.1016\/j.semperi.2025.152040_bib0101","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000487128","article-title":"Severe adverse reaction to Vemurafenib in a pregnant woman with metastatic melanoma","volume":"11","author":"de Haan","year":"2018","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.semperi.2025.152040_bib0102","doi-asserted-by":"crossref","first-page":"e00142","DOI":"10.1016\/j.crwh.2019.e00142","article-title":"Treatment of metastatic malignant melanoma during pregnancy with a BRAF kinase inhibitor","volume":"24","author":"Pagan","year":"2019","journal-title":"Case Rep Womens Health"},{"issue":"5","key":"10.1016\/j.semperi.2025.152040_bib0103","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14740338.2021.1893299","article-title":"Risks of molecular targeted therapies to fertility and safety during pregnancy: a review of current knowledge and future needs","volume":"20","author":"Lorenzi","year":"2021","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"10.1016\/j.semperi.2025.152040_bib0104","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00105-023-05166-x","article-title":"[Fertility, teratogenicity, and contraception during therapy with BRAF\/MEK inhibitors]","volume":"74","author":"Livingstone","year":"2023","journal-title":"Dermatologie (Heidelb)"},{"key":"10.1016\/j.semperi.2025.152040_bib0105","first-page":"775","article-title":"Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma","volume":"8","author":"Swaika","year":"2014","journal-title":"Drug Des Devel Ther"},{"issue":"8","key":"10.1016\/j.semperi.2025.152040_bib0106","doi-asserted-by":"crossref","first-page":"e1209","DOI":"10.1634\/theoncologist.2019-0747","article-title":"Prognosis and management of BRAF V600E-mutated pregnancy-associated melanoma","volume":"25","author":"Ziogas","year":"2020","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.semperi.2025.152040_bib0107","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1200\/JCO.2012.45.2870","article-title":"Treatment of metastatic malignant melanoma with vemurafenib during pregnancy","volume":"31","author":"Maleka","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.semperi.2025.152040_bib0108","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.clindermatol.2012.08.016","article-title":"Chemotherapy in the management of advanced cutaneous malignant melanoma","volume":"31","author":"Luke","year":"2013","journal-title":"Clin Dermatol"},{"issue":"13","key":"10.1016\/j.semperi.2025.152040_bib0109","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133103","article-title":"Transplacental passage and fetal effects of antineoplastic treatment during pregnancy","volume":"14","author":"Triarico","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.semperi.2025.152040_bib0110","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1200\/JCO.2003.12.149","article-title":"Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant","volume":"21","author":"Alexander","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semperi.2025.152040_bib0111","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mce.2015.09.020","article-title":"Steroid hormone influence on melanomagenesis","volume":"417","author":"Mitkov","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"10.1016\/j.semperi.2025.152040_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.07.022","article-title":"Melanoma risk after in vitro fertilization: a review of the literature","volume":"79","author":"Berk-Krauss","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5Part B","key":"10.1016\/j.semperi.2025.152040_bib0113","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ijwd.2021.06.005","article-title":"Hormone therapy and melanoma in women","volume":"7","author":"Hill","year":"2021","journal-title":"Int J Womens Dermatol"},{"issue":"2","key":"10.1016\/j.semperi.2025.152040_bib0114","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.det.2006.01.003","article-title":"Nevi and melanoma in pregnancy","volume":"24","author":"Driscoll","year":"2006","journal-title":"Dermatol Clin"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000525000175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000525000175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T11:50:56Z","timestamp":1741866656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000525000175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0146000525000175"],"URL":"https:\/\/doi.org\/10.1016\/j.semperi.2025.152040","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma in pregnancy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semperi.2025.152040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152040"}}